Targeting the Tie2–αvβ3 integrin axis with bi-specific reagents for the inhibition of angiogenesisTomer Shlamkovich, Niv Papo|BMC Biology|2018Cited by 16
Utilizing combinatorial engineering to develop Tie2 targeting antagonistic angiopoetin-2 ligands as candidates for anti-angiogenesis therapyTomer Shlamkovich, Niv Papo|Oncotarget|2017Cited by 4